Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial.
Yun S, Comín-Colet J, Calero-Molina E, Hidalgo E, José-Bazán N, Cobo Marcos M, Soria T, Llàcer P, Fernández C, García-Pinilla JM, Cruzado C, González-Franco Á, García-Marina EM, Morales-Rull JL, Solé C, García-Romero E, Núñez J, Civera J, Fernández C, Faraudo M, Moliner P, Formiga F, de-Juan Bagudá J, Zegri-Reiriz I, Verdú-Rotellar JM, Vela E, Monterde D, Piera-Jiménez J, Carot-Sans G, Enjuanes C; HERMeS trial investigators group.
Yun S, et al. Among authors: llacer p.
Lancet Digit Health. 2025 May;7(5):100866. doi: 10.1016/j.landig.2025.02.006. Epub 2025 May 14.
Lancet Digit Health. 2025.
PMID: 40374486
Free article.
Clinical Trial.